Cooperative Oligomeric Peptide Combinations Enhance the Predicted Therapeutic Profile of SET-M33
Antibiotics · 09.06.2026 · 15 (6) · 591
DOI: 10.3390/antibiotics15060591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 09.06.2026. Verfasst von Ismael Castanon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, 4014 Stavanger, Norway. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union Horizon Europe MSCA DN-ID.
Abstract (Originalsprache)
Background/Objectives: Antimicrobial peptides (AMPs) are promising candidates against multidrug-resistant bacteria, although their clinical translation is frequently limited by cytotoxicity. In this study, we investigated whether combinations of structurally related oligomeric analogs could cooperatively enhance bacterial membrane targeting while redistributing the associated cytotoxic burden.
Methods
Monomeric, dimeric, and tetrameric AMPs were evaluated through antimicrobial susceptibility testing, checkerboard interaction assays, RAW 264.7 macrophage cytotoxicity assays, and all-atom molecular dynamics simulations, including biased membrane insertion and umbrella sampling analyses. In addition, we introduced the Combinatorial Therapeutic Index (CTI) as an exploratory metric to estimate the predicted reduction in cytotoxic burden associated with peptide combinations.
Results
Cytotoxicity varied substantially among oligomeric forms, with larger and more hydrophobic peptides, particularly tetramers, exhibiting the highest cytotoxicity. Additive effects were observed in checkerboard assays involving linear, dimeric, and tetrameric forms, supporting the redistribution of the toxic burden and enabling the beneficial membrane-interaction properties of hydrophobic linear peptides to be leveraged at lower cytotoxic cost. Predicted therapeutic improvement ranged from approximately twofold for the SET-M33:L33 combination to nearly ninefold for the SET-M33:DIM-33:L8 triple combination. Molecular dynamics simulations revealed non-redundant membrane interaction behaviors, with smaller peptides exhibiting deeper membrane insertion and the dimeric form favoring interfacial membrane engagement.
Conclusions
These findings support a cooperative formulation strategy in which structurally related SET-M33 oligomers contribute complementary antibacterial functions while reducing the predicted cytotoxic burden. Further experimental validation using direct cytotoxicity assays of complete peptide mixtures will be necessary to confirm the therapeutic potential of these formulations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, 4014 Stavanger, Norway.
- Department of Medical Biotechnology, University of Siena, 53100 Siena, Italy.
- SetLance SRL, Via Fiorentina 1, 53100 Siena, Italy.
- Clinical Pathology Unit, Azienda Ospedaliera, Universitaria Senese, 53100 Siena, Italy.
ORCID-Profile: Alessandro Rencinai, Laura Cresti, Eva Tollapi, Chiara Falciani, Alessandro Pini
Förderung
- European Union Horizon Europe MSCA DN-ID
Zitieren
APA
Castanon, I., Cappello, G., Rencinai, A., Cresti, L., Tollapi, E., Falciani, C., & Pini, A. (2026). Cooperative Oligomeric Peptide Combinations Enhance the Predicted Therapeutic Profile of SET-M33. Antibiotics, 15(6), 591. https://doi.org/10.3390/antibiotics15060591
Vancouver
Castanon I, Cappello G, Rencinai A, Cresti L, Tollapi E, Falciani C, et al. Cooperative Oligomeric Peptide Combinations Enhance the Predicted Therapeutic Profile of SET-M33. Antibiotics. 2026;15(6):591. doi:10.3390/antibiotics15060591
BibTeX
@article{Castanon2026,
author = {Castanon, Ismael and Cappello, Giovanni and Rencinai, Alessandro and Cresti, Laura and Tollapi, Eva and Falciani, Chiara and Pini, Alessandro},
title = {Cooperative Oligomeric Peptide Combinations Enhance the Predicted Therapeutic Profile of SET-M33},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {6},
pages = {591},
doi = {10.3390/antibiotics15060591}
}
EUVIMED